Key points are not available for this paper at this time.
To identify patients with new onset atrial fibrillation * To assess thromboembolic risk and to start early treatment with antithrombotic drugs-warfarin will be needed for most patients, while aspirin may be suitable for patients aged <65 years with no cardiac risk factors or structural heart disease * To help to monitor treatment with anticoagulants * To refer appropriate patients to a cardiologist for further assessment (including echocardiography) and consideration of cardioversion * To be aware of potential drug interactions and toxicity with antiarrhythmic drugs and anticoagulants
Lip et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: